Stock Below Rs 25 Announces 67:267 Rights Issue – Check Record Date
Rights issue of Rs 699.99 crore announced with full promoter backing and structured payment terms
Infibeam Avenues Limited, a leading company in payment gateway development services and e-commerce infrastructure, has approved the launch of a rights issue to raise up to Rs 699.99 crore. The decision was taken at the Rights Issue Committee meeting held on June 19, 2025.
The rights issue comprises 69,99,85,723 partly paid-up equity shares of face value Rs 1 each, priced at Rs 10 per share (including a premium of Rs 9 per share). The amount payable per Rights Equity Share will be made in two tranches—Rs 5 per share on application (Rs 0.50 towards face value and Rs 4.50 towards premium), and the remaining Rs 5 on a final call to be determined by the Board or the Rights Issue Committee.
The record date to determine eligible shareholders is June 26, 2025. Eligible shareholders will be entitled to 67 rights equity shares for every 267 fully paid-up equity shares held on the record date.
The issue will open on Thursday, July 3, 2025, and close on Friday, July 11, 2025. The last date for on-market renunciation of rights entitlements is Monday, July 7, 2025, and for off-market renunciation, it is Thursday, July 10, 2025.
Assuming full subscription, the total outstanding equity shares will increase from 2,78,94,95,346 to 3,48,94,81,069.
The Promoter and Promoter Group have confirmed that they will subscribe to the rights entitlements to the full extent and may renounce them, in full or in part, only in favour of members of the Promoter and Promoter Group. They also intend to subscribe to additional shares and any unsubscribed portion of the issue, subject to compliance with minimum public shareholding norms under the Securities Contracts (Regulation) Rules, 1957, and SEBI (LODR) Regulations, 2015. They have no intention to renounce rights in favour of any specific investor(s).
Disclaimer: The article is for informational purposes only and not investment advice.